.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
.

.
"the drug must be administered at the right time point during development," he said..
ai-based software may help predict risk of dementia..glenmark pharma launches generic version of asthma drug in denmark
. /